MSACL 2023 : Ballantyne

MSACL 2023 Industry Workshop Presentation

*This Podium Presentation is occuring in the context of an Industry Workshop that starts at the time below. Its actual start time may be up to 40 minutes later, depending on order of presentation if there are multiple presentations planned by the workshop host.

Workshop Host:Waters
Day:Wednesday April 5
Time:7:00*
Location:Steinbeck 3

The Evolving Power of LC-MS/MS Technology within Endocrinology
David Ballantyne
Waters Corporation

Summary

LC-MS/MS is rapidly becoming the gold standard for quantifying different classes of analytes in endocrinology and peptide research. The power of greater selectivity and analytical sensitivity using LC-MS/MS is critical in understanding the status of biochemical pathways. The enhanced performance observed on these platforms provides increased confidence in the results, enabling you to make better decisions based on more accurate information.

Greater analytical sensitivity is a goal that drives improvements in precision, leading to clearer insights into results down to low physiological concentrations. Here we will discuss the latest introduction to the Waters MassTrak™ IVD system family, which is shown to be analytically sensitive and efficient, helping to reduce cost and improve the quality of your data.

Learning objectives:
• An introduction to the latest addition to Waters MassTrak IVD System for clinical laboratories
• The importance of selectivity in endocrinology research in obtaining high quality data
• How the latest addition to Waters MassTrak IVD System addresses the needs of those key research applications, including steroid hormone and peptide analysis